Lipid nanoparticles for mRNA delivery

Sdílet
Vložit
  • čas přidán 24. 08. 2024
  • Title: Lipid nanoparticles for mRNA delivery
    Speaker: Marianna Yanez Arteta, AstraZeneca.
    This talk was part of the PhD school, Neutrons in Life Science and Biomaterials, hosted by LINXS on behalf of SwedNess in June 2021.
    Read more about LINXS, www.linxs.se

Komentáře • 24

  • @user-zo5jk8rm4j
    @user-zo5jk8rm4j Před 3 měsíci

    This presentation is so informative and professional! I love it and the presentator as well.

  • @HybridParentSupport
    @HybridParentSupport Před 9 měsíci

    The cdc website is not up to date. Neither are the websites for my state/county/city health departments. It’s should be unacceptable with all the taxes we pay.

  • @dianemallon7207
    @dianemallon7207 Před 8 měsíci

    Yes, thanks for the LNP's, brilliant

  • @ladushky1
    @ladushky1 Před 7 měsíci

    Thank you very much for sharing your presentation!

  • @oibal60
    @oibal60 Před 2 lety +1

    Superb presentation.

  • @shutincharlie3461
    @shutincharlie3461 Před 2 měsíci

    How much lipid nano particle is safe for the human body? .....none , there has been many studies done and there is NO safe amount know.

  • @wahyuwidayat2872
    @wahyuwidayat2872 Před 9 měsíci

    hello , can you share calculation in aspreadsheet or excel...? thanks

  • @Andy_Paris
    @Andy_Paris Před 2 lety +1

    Wow, @2:40, the human body complexity is the challenge.

  • @soniagarg4231
    @soniagarg4231 Před rokem

    Nice presentation..can you please share calculation excel sheet .

    • @estherjames821
      @estherjames821 Před rokem

      Did you get the excel sheet shared to you?

    • @arslansiilaa
      @arslansiilaa Před 3 měsíci

      Did you get the sheet. I also need it

  • @zachocracy
    @zachocracy Před 2 lety

    3:20 the discovery of mRNA is irrelevant when they only focus on the toxdata and biodistribution data of prior LNPs while ignoring the current payload, _right?_
    Aka a platform approach

    • @zachocracy
      @zachocracy Před 2 lety

      Which was siRNA... yet after definition changes we define it the most broad way possible: a vax...
      Well a cigarette is now a vax by increasing mucousal immunity against respiratory illness... of course broad definitions are not honest or indicative of reality.

  • @user-fd3kh7ev6h
    @user-fd3kh7ev6h Před 2 lety +1

    شيء

  • @zachocracy
    @zachocracy Před 2 lety

    *Copy your competition:**
    Luckily you can just use a "platform approach" of exisiting LNPs and mitigate inflammation.. ignore 60% of nonclinicals and then the novel accelerated approval process will just push it through if your user fees are high enough 🤦‍♂️
    I mean just look at Moderna's Labroots Webinar by Joseph Senn (titled) _Evolution of a Platform Based Non-Clinical Assessment Approach for Vaccines_

    • @zachocracy
      @zachocracy Před 2 lety

      I also have screen recorded it since YT deleted it after 40 views for whatever reason

  • @zachocracy
    @zachocracy Před 2 lety

    LNPs are so incredibly safe that we can completely ignore the payload inside, whether siRNA, mRNA, cDNA, or otherwise.
    - Is this the same with magnetofection?
    _"Well we're using the same iron, so it's fine!"_

    • @zachocracy
      @zachocracy Před 2 lety

      🤷‍♂️ _i thought it was funny_

  • @joannaslawecka8262
    @joannaslawecka8262 Před 2 lety

    Why are the lipids used in the formulation unsaturated? How does that influence the structure?

    • @biopharmmarkets2115
      @biopharmmarkets2115 Před 8 měsíci

      If I had to guess it’s because LNP’s can actually form many structures depending on the head to tail ratio of the lipid (ie they can form micelles, inverse micelles, linear bilayers, etc). It’s important to design the lipids so that that the formation of liposomes is more favorable than those other types of structures